International Stem Cell (ISCO) Income from Continuing Operations (2016 - 2025)
Historic Income from Continuing Operations for International Stem Cell (ISCO) over the last 17 years, with Q3 2025 value amounting to $57000.0.
- International Stem Cell's Income from Continuing Operations rose 14560.0% to $57000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$58000.0, marking a year-over-year increase of 9150.81%. This contributed to the annual value of -$213000.0 for FY2024, which is 7344.14% up from last year.
- As of Q3 2025, International Stem Cell's Income from Continuing Operations stood at $57000.0, which was up 14560.0% from $129000.0 recorded in Q2 2025.
- International Stem Cell's Income from Continuing Operations' 5-year high stood at $129000.0 during Q2 2025, with a 5-year trough of -$641000.0 in Q3 2021.
- Its 5-year average for Income from Continuing Operations is -$181684.2, with a median of -$131000.0 in 2023.
- Its Income from Continuing Operations has fluctuated over the past 5 years, first crashed by 885000.0% in 2023, then soared by 16368.72% in 2024.
- International Stem Cell's Income from Continuing Operations (Quarter) stood at -$364000.0 in 2021, then surged by 107.69% to $28000.0 in 2022, then crashed by 1735.71% to -$458000.0 in 2023, then soared by 102.62% to $12000.0 in 2024, then skyrocketed by 375.0% to $57000.0 in 2025.
- Its Income from Continuing Operations was $57000.0 in Q3 2025, compared to $129000.0 in Q2 2025 and -$256000.0 in Q1 2025.